title: [Long-term follow-up and bone imaging in acquired osteochondrodysplasia in a female patient with thalassemia and desferrioxamine hypersensitivity].
abstract: We report a female thalassaemia major patient who developed short stature and osteochondrodystrophic lesions during therapy with desferrioxamine (DFX). Healing was noted after the dose of DFX was decreased for 3 years. Unfortunately the spinal cartilage abnormalities did not change suggesting an irreversibility of the ossification process.
authors: Centro Microcitemie, A.O. Umberto I, Siracusa.
authors: A
authors: A
authors: Mangiagli
authors: V
authors: V
authors: De Sanctis
authors: S
authors: S
authors: Campisi
authors: G
authors: G
authors: Di Silvestro
authors: L
authors: L
authors: Urso
mesh_terms: D003676:Deferoxamine / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007502:Iron Chelating Agents / Q000009:adverse effects*; D010009:Osteochondrodysplasias / Q000139:chemically induced*; D013997:Time Factors; D017086:beta-Thalassemia / Q000188:drug therapy*
chemical_list: D007502:Iron Chelating Agents; D003676:Deferoxamine